UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 11, 2004
BSD MEDICAL CORPORATION
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-10783 75-1590407
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
2188 West 2200 South
Salt Lake City, Utah 84119
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (801) 972-5555
N/A
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13a-4(c))
Item 7.01. Regulation FD Disclosure.
BSD Medical Corporation issued a press release on November 11, 2004. A copy of
the press release is hereby furnished as Exhibit 99.1 attached hereto Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits
99.1 Press Release of BSD Medical Corporation dated November 11, 2004
For Your Review and Approval
BSD Medical Signs Best Medical International as U.S. Sales Agent
SALT LAKE CITY, November 11, 2004--BSD Medical Corp. (OTCBB:BSDM) today
announced that it has entered into an agreement with Best Medical International,
Inc. to act as BSD's sales agent for sales of its BSD-500 system in the United
States. Best Medical is a leading supplier of products for cancer treatment
therapies using targeted radiation sources (brachytherapy).
Hyrum A. Mead, president of BSD Medical said, "For 27 years Best Medical
has been a foremost supplier of products used in the market segment targeted for
the BSD-500. The BSD-500 is used in combination with brachytherapy to
substantially improve both tumor destruction and long-term survival from cancer,
as compared to brachytherapy treatments alone. We expect Best Medical's
reputation for excellent customer service, high quality products and customer
satisfaction, as provided by its strong sales force, to contribute greatly as we
partner in our sales efforts for the BSD-500."
Krish Suthanthiran, President of Best Medical International said, "BSD and
Best Medical share a common market. Best has frequent communications with the
physicians and clinics that should be utilizing BSD technology. We intend to
leverage the disposable business to sell the capital equipment and vice-versa."
Two new FDA approvals were granted within the past 13 months for the
BSD-500. These approvals culminated six years of planning and development for
the new system. The BSD-500 is compact, portable and ergonomically engineered
for ease and convenient use in a demanding hospital environment. The ultimate
sales objective for the BSD-500 is to achieve 1:1 utilization in combination
with the 1,500 brachytherapy systems currently installed--a total potential
market of over $300 million.
BSD Medical Corporation is a leading developer of microwave systems used
in the treatment of cancer. For more information about BSD Medical Corp., its
products and therapies visit www.BSDMC.com. For further information about Best
Medical International, Inc. visit www.Best-Medical.com.
Statements contained in this press release that are not historical facts
are forward looking statements, as that item is defined in the Private
Securities Litigation Reform Act of 1995. All forward-looking statements,
including statements about the projected market for the BSD-500, are subject to
risks and uncertainties, some of which are detailed in part in the Company's
filings with the Securities and Exchange Commission.
###
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: November 11, 2004
By: /s/ Hyrum A. Mead
-------------------------------
President